GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (OTCPK:HNGZY) » Definitions » Long-Term Capital Lease Obligation

HNGZY (Hangzhou Tigermed Consulting Co) Long-Term Capital Lease Obligation : $52.9 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Long-Term Capital Lease Obligation?

Hangzhou Tigermed Consulting Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $52.9 Mil.

Hangzhou Tigermed Consulting Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 ($62.8 Mil) to Dec. 2024 ($54.8 Mil) and declined from Dec. 2024 ($54.8 Mil) to Mar. 2025 ($52.9 Mil).

Hangzhou Tigermed Consulting Co's annual Long-Term Capital Lease Obligation declined from Dec. 2022 ($70.1 Mil) to Dec. 2023 ($59.3 Mil) and declined from Dec. 2023 ($59.3 Mil) to Dec. 2024 ($54.8 Mil).


Hangzhou Tigermed Consulting Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Long-Term Capital Lease Obligation Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.67 63.88 70.14 59.26 54.85

Hangzhou Tigermed Consulting Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.58 53.31 62.76 54.85 52.85

Hangzhou Tigermed Consulting Co  (OTCPK:HNGZY) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Hangzhou Tigermed Consulting Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's offered services include bioanalytical, medical writing, biostatistical analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.